IGF-1R can be founded in most solid tumors and hematological malignancies examined to date, and IGF-2 overexpression, IGFBP modulations, and IGF-2R down-regulation have also been founded in cancer cells [46,61,62]. This evidence concerns the gene IGF2R and cancer.